Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000377392 | SCV000334307 | uncertain significance | not provided | 2015-08-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001400678 | SCV001602485 | likely benign | Wolman disease | 2023-08-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002319474 | SCV002608886 | likely benign | Cardiovascular phenotype | 2019-11-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001828188 | SCV002088914 | likely benign | Lysosomal acid lipase deficiency | 2020-08-08 | no assertion criteria provided | clinical testing |